Results 141 to 150 of about 17,859 (212)

Structure and dynamics determine G protein coupling specificity at a class A GPCR. [PDF]

Sci Adv
Casiraghi M, Wang H, Brennan PC, Habrian C, Hübner H, Schmidt MF, Maul L, Pani B, Bahriz SMFM, Xu B, Staffen N, Assafa TE, Chen B, White E, Sunahara RK, Inoue A, Xiang YK, Lefkowitz RJ, Isacoff EY, Nucci N, Gmeiner P, Lerch MT, Kobilka BK.   +22 more
europepmc   +1 more source

Pharmacoeconomic evaluation of ICS-LABA therapy in pediatric asthma: a cost-effectiveness and cost-utility analysis. [PDF]

Front Pharmacol
Dai F, Xu J, Xu J, Li W.
europepmc   +1 more source

Pharmacologic Therapies for Preventing Chronic Obstructive Pulmonary Disease Exacerbations: A Comprehensive Review. [PDF]

Tuberc Respir Dis (Seoul)
Lee HW.
europepmc   +1 more source

Coverage of Recommended Vaccination Among Adult Patients With Asthma in Riyadh, Saudi Arabia. [PDF]

Cureus
Almishrafi HA, Alhaqbani AA, Alshammari WI, Alqulaysh BF, Alnasyan AY, Alwadie SA, Almozini MA, Alghamdi MA, Alhqyal AS, Alhabi NY.   +9 more
europepmc   +1 more source

Call for the alignment of Medicare Part D formularies with clinical treatment guidelines for asthma. [PDF]

J Manag Care Spec Pharm
Lao A, McNamara A, Chan LLS, Smith D.
europepmc   +1 more source

Recurrent Pulmonary Infection Caused by <i>Schizophyllum commune</i>: A Case Report and Management of Inflammation. [PDF]

Respirol Case Rep
Ren S, Xu P, Dai M, Chen R, Tang H.
europepmc   +1 more source

Comparative analysis of real-world data on the efficacy and safety of and adherence to ICS/LABA combinations in asthma management. [PDF]

Respir Res
Park HS, Lee J, Kim H, Woo SD.
europepmc   +1 more source

Non-antifungal medications administered during fungal infections drive drug tolerance and resistance in <i>Candida albicans</i>. [PDF]

J Med Microbiol
Obermeier M, Esparza-Mora MA, Heese O, Cohen N, Varma SJ, Tober-Lau P, Hartl J, Kurth F, Berman J, Ralser M.   +9 more
europepmc   +1 more source

Unveiling Novel Arginase Inhibitors for Cutaneous Leishmaniasis Using Drug Repurposing and Virtual Screening Approaches. [PDF]

J Cell Biochem
Barreto EM, Pereira GRC, Arêas IS, Fortes JM, Domingos ADS, Cabral LM, Rodrigues CR, de Souza AMT, Abrahim-Vieira BA.   +8 more
europepmc   +1 more source

Exploring SARS-CoV‑2 Spike RBD Pockets as Targets for Generic Drugs: A Combined Computational, Biophysical, and Biological Approach. [PDF]

ACS Omega
García-Marín J, Francés-Gómez C, Forcada-Nadal A, Adhav A, Marco-Marín C, Rubio V, Marina A, Llácer JL, Geller R, Martín-Santamaría S.   +9 more
europepmc   +1 more source